AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Dec 5, 2014
30016_dirs_2014-12-05_619dd8ca-b9ff-416f-a406-99131dc34f0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-12-03
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-03 | Common Stock | M | 29000 | $28.655 | Acquired | 445081 | Direct |
| 2014-12-03 | Common Stock | S | 10958 | $148.1178 | Disposed | 434123 | Direct |
| 2014-12-03 | Common Stock | S | 18042 | $148.7208 | Disposed | 416081 | Direct |
| 2014-12-04 | Common Stock | M | 15000 | $34.37 | Acquired | 431081 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-03 | Non-Qualified Stock Option (right to buy) | $28.6550 | M | 29000 | Disposed | 2015-02-02 | Common Stock (29000) | Direct |
| 2014-12-04 | Non-Qualified Stock Option (right to buy) | $34.37 | M | 15000 | Disposed | 2016-02-13 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2014.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $147.49 to $148.48, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $148.49 to $149.00, inclusive.
F4: Grant of options to buy shares of common stock that became exercisable as to 20,000 shares on 02/03/2006, 02/03/2007, 02/03/2008 and 02/03/2009, and the remaining 16,512 shares on 02/03/2010.
F5: Grant of options to buy shares of common stock that became exercisable as to 15,999 shares on 02/14/2010 and 02/14/2013, 16,000 shares on 02/14/2011 and 02/14/2012, and the remaining 13,091 shares on 02/14/2014.